REG - EKF Diagnostics Hldg - Result of AGM and Voting Results

EKF Diagnostics HoldingsAnnouncement

17/05/2023 12:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230517:nRSQ7560Za&default-theme=true

RNS Number : 7560Z  EKF Diagnostics Holdings PLC  17 May 2023

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces that at it's Annual General Meeting ("AGM") held earlier
today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

             For                   Against                                          Withheld
 Resolution  Votes        %        Votes                                     %      Votes
 1           299,140,487  99.99%                   25,430                    0.01%                 12,000
 2           299,164,209  100.00%                    1,708                   0.00%                 12,000
 3           296,684,235  99.17%              2,481,682                      0.83%                 12,000
 4           277,821,196  92.87%            21,344,721                       7.13%                 12,000
 5           299,127,062  99.99%                   38,855                    0.01%                 12,000
 6           298,964,519  99.95%                 158,855                     0.05%                 54,543
 7           283,417,147  94.75%            15,704,227                       5.25%                 56,543
 8           239,170,516  93.84%            15,704,227                       6.16%          44,303,174
 9           242,369,025  99.97%                   72,261                    0.03%          56,736,631
 10          290,020,135  96.94%              9,145,782                      3.06%                 12,000

 

 

 

 

 EKF Diagnostics Holdings plc                                 www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair / Marc Davies, CFO             Tel: +44 (0)29 2071 0570

 Singer Capital Markets (Nominated Adviser & Broker)                                        Tel: +44 (0)20 7496 3000
 Aubrey Powell / George Tzimas / Oliver Platts

 Walbrook PR Limited               Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Lianne Applegarth  Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

·    Point-of-Care analysers in the key areas of Hematology and Diabetes,
as well as Central Laboratory products including clinical chemistry reagents,
analysers and centrifuges

 

·    Life Sciences services provide specialist manufacture of enzymes and
custom products for use in diagnostic food and industrial applications, as
well as other higher value Contract Manufacturing services

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGNKOBQKBKDOPD